The role of natural killer cells in curbing neuroinflammation

Journal of Neuroimmunology

Volumn 191, Issue 1-2, 2007, Pages 2-7

  Segal, Benjamin M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Experimental autoimmune encephalomyelitis; Immunoregulation; Multiple sclerosis; Natural killer cells

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; CELL MIGRATION; CYTOLYSIS; DEMYELINATING DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TARGET CELL; TUMOR CELL; VIRUS INFECTION;

ANIMALS; BRAIN; CELL MOVEMENT; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNOTHERAPY; KILLER CELLS, NATURAL; MICE; MULTIPLE SCLEROSIS; RECEPTORS, CHEMOKINE;

EID: 35848934131     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.09.006     Document Type: Review

References (55)

1. Backstrom E., Chambers B.J., Ho E.L., Naidenko O.V., Mariotti R., Fremont D.H., Yokoyama W.M., Kristensson K., and Ljunggren H.G. Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions. Eur. J. Immunol. 33 (2003) 92-100
2. Backstrom E., Ljunggren H.G., and Kristensson K. NK cell-mediated destruction of influenza A virus-infected peripheral but not central neurones. Scand. J. Immunol. 65 (2007) 353-361
3. Baecher-Allan C., and Hafler D.A. Human regulatory T cells and their role in autoimmune disease. Immunol. Rev. 212 (2006) 203-216
4. Benczur M., Petranyl G.G., Palffy G., Varga M., Talas M., Kotsy B., Foldes I., and Hollan S.R. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor. Clin. Exp. Immunol. 39 (1980) 657-662
5. Bielekova B., Catalfamo M., Reichert-Scrivner S., Packer A., Cerna M., Waldmann T.A., McFarland H., Henkart P.A., and Martin R. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc. Natl. Acad. Sci. U S A 103 (2006) 5941-5946
6. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., and Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17 (1999) 189-220
7. Borrego F., Masilamani M., Marusina A.I., Tang X., and Coligan J.E. The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance. Immunol. Res. 35 (2006) 263-278
8. Braakman E., van Tunen A., Meager A., and Lucas C.J. Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit. Clin. Exp. Immunol. 66 (1986) 285-294
9. Carrier Y., Yuan J., Kuchroo V.K., and Weiner H.L. Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity. J. Immunol. 178 (2007) 172-178
10. Diefenbach A., Jamieson A.M., Liu S.D., Shastri N., and Raulet D.H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1 (2000) 119-126
11. Furlan R., Bergami A., Cantarella D., Brambilla E., Taniguchi M., Dellabona P., Casorati G., and Martino G. Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma. Eur. J. Immunol. 33 (2003) 1830-1838
12. Galazka G., Stasiolek M., Walczak A., Jurewicz A., Zylicz A., Brosnan C.F., Raine C.S., and Selmaj K.W. Brain-derived heat shock protein 70-peptide complexes induce NK cell-dependent tolerance to experimental autoimmune encephalomyelitis. J. Immunol. 176 (2006) 1588-1599
13. Gilbertson S.M., Shah P.D., and Rowley D.A. NK cells suppress the generation of Lyt-2+cytolytic T cells by suppressing or eliminating dendritic cells. J. Immunol. 136 (1986) 3567-3571
14. Hammarberg H., Lidman O., Lundberg C., Eltayeb S.Y., Gielen A.W., Muhallab S., Svenningsson A., Linda H., van Der Meide P.H., Cullheim S., Olsson T., and Piehl F. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J. Neurosci. 20 (2000) 5283-5291
15. Hauser S.L., Ault K.A., Levin M.J., Garovoy M.R., and Weiner H.L. Natural killer cell activity in multiple sclerosis. J. Immunol. 127 (1981) 1114-1117
16. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J.V., Steinman R.M., and Nussenzweig M.C. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194 (2001) 769-779
17. Hirsch R.L., and Johnson K.P. Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-alpha 2. Clin. Immunol. Immunopathol. 37 (1985) 236-244
18. Huang D., Shi F.D., Jung S., Pien G.C., Wang J., Salazar-Mather T.P., He T.T., Weaver J.T., Ljunggren H.G., Biron C.A., Littman D.R., and Ransohoff R.M. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. Faseb J. 20 (2006) 896-905
19. Illes Z., Shimamura M., Newcombe J., Oka N., and Yamamura T. Accumulation of Valpha7.2-Jalpha33 invariant T cells in human autoimmune inflammatory lesions in the nervous system. Int. Immunol. 16 (2004) 223-230
20. Infante-Duarte C., Weber A., Kratzschmar J., Prozorovski T., Pikol S., Hamann I., Bellmann-Strobl J., Aktas O., Dorr J., Wuerfel J., Sturzebecher C.S., and Zipp F. Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients. FASEB J. 19 (2005) 1902-1904
21. Kastrukoff L.F., Morgan N.G., Zecchini D., White R., Petkau A.J., Satoh J., and Paty D.W. A role for natural killer cells in the immunopathogenesis of multiple sclerosis. J. Neuroimmunol. 86 (1998) 123-133
22. Kastrukoff L.F., Lau A., Wee R., Zecchini D., White R., and Paty D.W. Clinical relapses of multiple sclerosis are associated with 'novel' valleys in natural killer cell functional activity. J. Neuroimmunol. 145 (2003) 103-114
23. Kirwan S.E., and Burshtyn D.N. Regulation of natural killer cell activity. Curr. Opin. Immunol. 19 (2007) 46-54
24. Kreuzfelder E., Shen G., Bittorf M., Scheiermann N., Thraenhart O., Seidel D., and Grosse-Wilde H. Enumeration of T, B and natural killer peripheral blood cells of patients with multiple sclerosis and controls. Eur. Neurol. 32 (1992) 190-194
25. Lu L., Ikizawa K., Hu D., Werneck M.B., Wucherpfennig K.W., and Cantor H. Regulation of activated CD4+T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 26 (2007) 593-604
26. Matsumoto Y., Kohyama K., Aikawa Y., Shin T., Kawazoe Y., Suzuki Y., and Tanuma N. Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis. Eur. J. Immunol. 28 (1998) 1681-1688
27. Mehrotra P.T., Donnelly R.P., Wong S., Kanegane H., Geremew A., Mostowski H.S., Furuke K., Siegel J.P., and Bloom E.T. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J. Immunol. 160 (1998) 2637-2644
28. Miyara M., and Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends. Mol. Med. 13 (2007) 108-116
29. Morse R.H., Seguin R., McCrea E.L., and Antel J.P. NK cell-mediated lysis of autologous human oligodendrocytes. J. Neuroimmunol. 116 (2001) 107-115
30. Munschauer F.E., Hartrich L.A., Stewart C.C., and Jacobs L. Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls. J. Neuroimmunol. 62 (1995) 177-181
31. Nagaraj S., and Gabrilovich D.I. Myeloid-derived suppressor cells. Adv. Exp. Med. Biol. 601 (2007) 213-223
32. Nomura M., Takihara Y., Yasunaga T., and Shimada K. One of the retinoic acid-inducible cDNA clones in mouse embryonal carcinoma F9 cells encodes a novel isoenzyme of fructose 1,6-bisphosphatase. FEBS Lett. 348 (1994) 201-205
33. Oger J., Kastrukoff L.F., Li D.K., and Paty D.W. Multiple sclerosis: in relapsing patients, immune functions vary with disease activity as assessed by MRI. Neurology 38 (1988) 1739-1744
34. Rauch H.C., Montgomery I.N., and Kaplan J. Natural killer cell activity in multiple sclerosis and myasthenia gravis. Immunol. Invest. 14 (1985) 427-434
35. Refaeli Y., Van Parijs L., Alexander S.I., and Abbas A.K. Interferon gamma is required for activation-induced death of T lymphocytes. J. Exp. Med. 196 (2002) 999-1005
36. Rice G.P., Casali P., Merigan T.C., and Oldstone M.B. Natural killer cell activity in patients with multiple sclerosis given alpha interferon. Ann. Neurol. 14 (1983) 333-338
37. Roncarolo M.G., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., and Levings M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212 (2006) 28-50
38. Saikali P., Antel J.P., Newcombe J., Chen Z., Freedman M., Blain M., Cayrol R., Prat A., Hall J.A., and Arbour N. NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. J. Neurosci. 27 (2007) 1220-1228
39. Santoli D., Hall W., Kastrukoff L., Lisak R.P., Perussia B., Trinchieri G., and Koprowski H. Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis. J. Immunol. 126 (1981) 1274-1278
40. Saraste M., Irjala H., and Airas L. Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta. Neurol. Sci. 28 (2007) 121-126
41. Satoh J., Kim S.U., and Kastrukoff L.F. Absence of natural killer (NK) cell activity against oligodendrocytes in multiple sclerosis. J. Neuroimmunol. 26 (1990) 75-80
42. Satoh J., Kim S.U., and Kastrukoff L.F. Cytolysis of oligodendrocytes is mediated by killer (K) cells but not by natural killer (NK) cells. J. Neuroimmunol. 31 (1991) 199-210
43. Screpanti V., Wallin R.P., Grandien A., and Ljunggren H.G. Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells. Mol. Immunol. 42 (2005) 495-499
44. Serafini P., Borrello I., and Bronte V. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer. Biol. 16 (2006) 53-65
45. Smeltz R.B., Wolf N.A., and Swanborg R.H. Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: implications for autoimmunity. J. Immunol. 163 (1999) 1390-1397
46. Smyth M.J., Swann J., Cretney E., Zerafa N., Yokoyama W.M., and Hayakawa Y. NKG2D function protects the host from tumor initiation. J. Exp. Med. 202 (2005) 583-588
47. Takahashi K., Miyake S., Kondo T., Terao K., Hatakenaka M., Hashimoto S., and Yamamura T. Natural killer type 2 bias in remission of multiple sclerosis. J. Clin. Invest. 107 (2001) R23-R29
48. Takeda K., Hayakawa Y., Smyth M.J., Kayagaki N., Yamaguchi N., Kakuta S., Iwakura Y., Yagita H., and Okumura K. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat. Med. 7 (2001) 94-100
49. Traugott U., and Raine C.S. Further lymphocyte characterization in the central nervous system in multiple sclerosis. Ann. N Y Acad. Sci. 436 (1984) 163-180
50. Uchida A., Maida E.M., Lenzhofer R., and Micksche M. Natural killer cell activity in patients with multiple sclerosis: interferon and plasmapheresis. Immunobiology 160 (1982) 392-402
51. Vranes Z., Poljakovic Z., and Marusic M. Natural killer cell number and activity in multiple sclerosis. J. Neurol. Sci. 94 (1989) 115-123
52. Warren H.S., and Smyth M.J. NK cells and apoptosis. Immunol. Cell Biol. 77 (1999) 64-75
53. Willenborg D.O., Fordham S.A., Staykova M.A., Ramshaw I.A., and Cowden W.B. IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J. Immunol. 163 (1999) 5278-5286
54. Xu W., Fazekas G., Hara H., and Tabira T. Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 163 (2005) 24-30
55. Zhang B., Yamamura T., Kondo T., Fujiwara M., and Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186 (1997) 1677-1687